Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease

OBJECTIVE: Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease (AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a cerebrospinal fluid (CSF) marker of endothelial injury in preclinical AD. METHODS: Cognitively normal participants (Clinical Dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarawneh, Rawan, Kasper, Rachel S., Sanford, Jessie, Phuah, Chia‐Ling, Hassenstab, Jason, Cruchaga, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735377/
https://www.ncbi.nlm.nih.gov/pubmed/36342663
http://dx.doi.org/10.1002/acn3.51685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735377/
https://www.ncbi.nlm.nih.gov/pubmed/36342663
http://dx.doi.org/10.1002/acn3.51685

Ejemplares similares